Thalassemia, a hereditary blood disorder, leads to a significant decrease in hemoglobin production within red blood cells, causing anemic, tiredness and paleness. Anemia results from a shortage of healthy red blood cells capable of carrying oxygen, impacting overall health by reducing oxygen delivery to vital organs.
India has the largest number of children with Thalassemia major in the world – about 1 to 1.5 lakhs and almost 42 million carriers of ß (beta) thalassemia trait. About 10,000 -15,000 babies with thalassemia major are born every year.
The Mobifusion Thalassemia Pump is designed to provide reliable infusion for thalassemia patients. It infuses iron chelating agents with an easy-to-use programmable interface and control mechanism.
Mobifusion can be used while performing day-to-day activities
Mobifusion comes with Li-Po 7.4V 500mAh Battery with Compact Power for High-Performance medical Devices
Thalassemia impacts 4 in every 10,000 live births globally, with over 4 million carriers in India alone. Mobifusion Thalassemia Pump is a significant leap forward in providing specialized care for Thalassemia patients. From compact portability to intuitive controls, every aspect is meticulously engineered to enhance the patient experience and streamline treatment.
Prioritizing patient safety, especially for young users, our secure lock feature ensures the safeguarding of the infusion process. This provides peace of mind for both patients and caregivers throughout usage.
The Mobifusion stands out with its essential safety feature – visual and audio alarms. These alerts for occlusion, syringe near end, disengaged syringe, low battery, depleted battery, and unit malfunction ensure users stay informed about their therapy.